Information  X 
Enter a valid email address
  Print      Mail a friend       More announcements

Monday 04 May, 2020

JP Morgan Sec LLC

AbbVie Inc. 38.5(b)

RNS Number : 8338L
J.P. Morgan Securities LLC
04 May 2020
 

Ap27

 

 

FORM   38.5(b)

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 38.5(b) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITHOUT RECOGNISED INTERMEDIARY STATUS, 

OR WITH RECOGNISED INTERMEDIARY STATUS BUT NOT DEALING IN A CLIENT-SERVING CAPACITY

 

 

1.  KEY   INFORMATION

 

Nameofexemptprincipaltrader

J.P Morgan Securities LLC

Companydealtin

AbbVie Inc.

Classofrelevantsecuritytowhichthe dealingsbeingdisclosedrelate (Note 1)

Common stock

Date of dealing

1 May 2020

 

2.  INTERESTS AND SHORT POSITIONS

 

(a)  Interests   and   short   positions   (following   dealing)   in   the   class   of   relevant   security   dealt   in   (Note   2)

 

 

Long

Short

 

Number

 

(%)

Number

 

(%)

  11,284,177  0.76

 3,991,639  0.27

(2) Derivatives (other than options)

 5,748,819  0.39

 7,739,010  0.52

(3)Optionsandagreementstopurchase/sell

 767,000  0.05

 773,100  0.05

Total

  17,799,996  1.20

 12,503,749  0.84

             

 

 

(b)  Interests and short positions in relevant securities of the company, other than the class dealt in  (Note   2)

 

Classofrelevantsecurity:

Long

Short

 

Number

 

(%)

Number

 

(%)

 

 

(2) Derivatives (other than options)

 

 

(3)Optionsandagreementstopurchase/sell

 

 

Total

 

 

             

 

Ap28

 

 

3.  DEALINGS  (Note   3)

 

(a)  Purchases and sales

 

Purchase/sale

Numberofrelevantsecurities

Priceperunit (Note 4)

Sale (Borrow Return)

 

Purchases

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Sales

1,314,600

 

5

100

115

100

100

173

100

100

12

1,200

230

236

3,987

1

1

116

11,824

1

100

273

62

100

100

164

342

431

100

200

100

2,869

133

119

17,975

12,565

2,572

1

127

100

100

100

502

100

255

251

149

100

100

695

27

18,560

172

200

23,726

10

144

300

118

200

3,679

90

18,301

30,082

198

50,908

100

25,253

100

172

272

144

251,160

2

831

2

100

53

685

147

5,171

1

100

100

100

100

400

100

2,032

300

70

15,700

86,700

4

4,658

131

572

87

105

6,247

24

346

109

200

210

3

216

100

745

1,133

9,515

50

10

353

100

892

227

253

266

400

60,196

100

7,414

1,118

119

572

1,882

6,321

72

91

1,359

9,544

23

158

272

1,841

8

34

1,321

722

300

80

6

3,839

940

542

100

76

2,148

3,869

2,773

406

485

4,647

2,287

17

17

9,248

76

100

668

1

100

1,149

4

504

509

3,020

1

726

6

772

332

1,579

30

264

11

11

496

83

100

111

 

385

50,908

251,160

587

100

685

251

300

100

1

760

572

2,032

42

1

300

100

1

86,600

206

300

59

2

10

96

26

49

40

1

13

65

5

300

6

5

4,683

227

39

4,597

100

67

224

38

101

400

11,370

7,600

761

1,500

3,829

17,535

3,936

900

100

1,899

963

103

1

68

23,095

164

52

10

88

203

7

1

10

38

80

1

37

4

208

27

36

76

3

6

1

1

3

1

97

51

2

46

2

2

2

35

6

290

4

106

1

302

2

16

1

61

2

2

28

1

1

6

1

1

22

11

22

2

1

2

2

1

4

1

3

2

2

2

11

1

1

1

10

2

NA

 

80.8100 USD

80.8600 USD

80.8700 USD

80.8750 USD

80.9200 USD

80.9400 USD

80.9800 USD

80.9850 USD

81.0100 USD

81.0192 USD

81.0443 USD

81.0500 USD

81.1282 USD

81.1900 USD

81.2100 USD

81.3700 USD

81.4523 USD

81.4700 USD

81.4900 USD

81.5000 USD

81.5150 USD

81.5200 USD

81.5250 USD

81.5300 USD

81.5400 USD

81.5450 USD

81.5550 USD

81.5650 USD

81.5800 USD

81.5888 USD

81.5900 USD

81.6000 USD

81.6007 USD

81.6237 USD

81.6238 USD

81.6300 USD

81.6400 USD

81.6450 USD

81.6500 USD

81.6650 USD

81.6696 USD

81.6900 USD

81.7100 USD

81.7200 USD

81.7300 USD

81.7600 USD

81.8300 USD

81.8333 USD

81.8700 USD

81.8968 USD

81.9000 USD

81.9200 USD

81.9232 USD

81.9300 USD

81.9400 USD

81.9600 USD

81.9700 USD

82.0100 USD

82.0120 USD

82.0200 USD

82.0285 USD

82.0342 USD

82.0400 USD

82.0466 USD

82.0500 USD

82.0542 USD

82.0900 USD

82.1400 USD

82.1500 USD

82.1600 USD

82.1644 USD

82.1900 USD

82.2000 USD

82.2500 USD

82.2700 USD

82.3500 USD

82.3503 USD

82.4000 USD

82.4157 USD

82.4400 USD

82.4500 USD

82.4600 USD

82.4650 USD

82.4700 USD

82.4750 USD

82.4900 USD

82.5174 USD

82.5350 USD

82.5500 USD

82.5560 USD

82.5600 USD

82.5900 USD

82.5967 USD

82.5971 USD

82.5978 USD

82.6100 USD

82.6200 USD

82.6251 USD

82.6300 USD

82.6350 USD

82.6385 USD

82.6400 USD

82.6500 USD

82.6700 USD

82.6800 USD

82.6900 USD

82.6910 USD

82.7050 USD

82.7153 USD

82.7200 USD

82.7400 USD

82.7445 USD

82.7500 USD

82.7508 USD

82.7583 USD

82.7700 USD

82.7800 USD

82.7837 USD

82.7860 USD

82.7900 USD

82.7961 USD

82.7977 USD

82.8000 USD

82.8100 USD

82.8156 USD

82.8160 USD

82.8200 USD

82.8300 USD

82.8400 USD

82.8412 USD

82.8500 USD

82.8600 USD

82.8755 USD

82.8893 USD

82.8900 USD

82.8929 USD

82.8938 USD

82.8944 USD

82.9050 USD

82.9075 USD

82.9100 USD

82.9123 USD

82.9229 USD

82.9242 USD

82.9300 USD

82.9468 USD

82.9482 USD

82.9536 USD

82.9843 USD

82.9947 USD

82.9980 USD

83.0060 USD

83.0217 USD

83.0247 USD

83.0324 USD

83.0349 USD

83.0449 USD

83.0500 USD

83.0697 USD

83.0800 USD

83.1000 USD

83.1009 USD

83.1100 USD

83.1297 USD

83.1506 USD

83.1572 USD

83.1600 USD

83.1750 USD

83.1900 USD

83.1901 USD

83.1950 USD

83.2157 USD

83.2200 USD

83.2616 USD

83.5000 USD

83.5027 USD

83.5377 USD

83.6500 USD

83.9500 USD

84.0967 USD

 

81.9271 USD

82.0466 USD

82.1644 USD

82.2000 USD

82.3400 USD

82.3503 USD

82.3922 USD

82.3967 USD

82.4100 USD

82.4800 USD

82.4871 USD

82.4945 USD

82.5174 USD

82.5236 USD

82.5300 USD

82.5367 USD

82.5400 USD

82.5500 USD

82.5600 USD

82.6000 USD

82.6067 USD

82.6100 USD

82.6200 USD

82.6280 USD

82.6300 USD

82.6389 USD

82.6400 USD

82.7050 USD

82.7100 USD

82.7154 USD

82.7200 USD

82.7300 USD

82.7350 USD

82.7433 USD

82.7500 USD

82.7567 USD

82.7583 USD

82.7600 USD

82.7629 USD

82.7689 USD

82.7700 USD

82.7725 USD

82.7776 USD

82.7800 USD

82.7837 USD

82.7860 USD

82.7863 USD

82.7900 USD

82.7910 USD

82.7919 USD

82.7937 USD

82.7940 USD

82.7989 USD

82.8000 USD

82.8016 USD

82.8035 USD

82.8100 USD

82.8200 USD

82.8300 USD

82.8400 USD

82.8500 USD

82.8573 USD

82.8660 USD

82.8693 USD

82.8700 USD

82.8771 USD

82.8800 USD

82.8960 USD

82.8976 USD

82.9075 USD

82.9100 USD

82.9127 USD

82.9200 USD

82.9400 USD

82.9411 USD

82.9428 USD

82.9468 USD

82.9500 USD

82.9600 USD

82.9800 USD

83.0100 USD

83.0200 USD

83.0300 USD

83.0352 USD

83.0367 USD

83.0400 USD

83.0457 USD

83.0500 USD

83.0700 USD

83.0800 USD

83.0809 USD

83.0900 USD

83.0938 USD

83.0975 USD

83.1000 USD

83.1200 USD

83.1300 USD

83.1400 USD

83.1500 USD

83.1600 USD

83.1700 USD

83.1800 USD

83.1900 USD

83.2286 USD

83.2300 USD

83.2400 USD

83.2500 USD

83.2600 USD

83.2800 USD

83.2827 USD

83.2900 USD

83.2936 USD

83.3100 USD

83.3300 USD

83.3500 USD

83.3800 USD

83.3900 USD

83.4100 USD

83.4400 USD

83.4533 USD

83.4800 USD

83.4900 USD

83.5000 USD

83.5027 USD

83.5500 USD

83.5700 USD

83.7200 USD

83.7510 USD

83.9100 USD

 

 

(b)  Derivatives transactions (other than options transactions)

 

Productname,

e.g. CFD

Natureoftransaction

(Note 5)

Numberofrelevantsecurities

(Note 6)

Priceperunit

(Note 4)

Equity Swaps

Long

 

 

Short

685

227

 

50,908

251,160

400

80

76

11

82.3503 USD

82.7583 USD

 

82.0466 USD

82.1644 USD

82.7837 USD

82.9075 USD

82.9468 USD

83.5027 USD

 

 

(c)  Options transactions in respect of existing relevant securities

 

 

(i)  Writing,   selling, purchasing or varying

 

Productname,

e.g. call option

Writing, selling,purchasing,varyingetc.

Numberofsecurities towhichtheoptionrelates (Note 7)

Exercise price

(USD)

Type, e.g.American,Europeanetc.

Expiry date

Optionmoney paid/receivedperunit (USD)

(Note 4)

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Purchasing

Purchasing

Purchasing

Purchasing

Purchasing

Purchasing

Purchasing

Purchasing

Purchasing

Purchasing

Purchasing

Purchasing

Purchasing

Selling

Selling

Selling

Selling

Selling

Selling

Purchasing

Purchasing

Purchasing

Purchasing

Purchasing

Purchasing

Purchasing

Purchasing

Purchasing

Purchasing

Purchasing

Purchasing

Purchasing

Purchasing

Purchasing

Purchasing

Selling

Selling

Selling

Selling

Selling

Selling

100

 600

 100

 200

 100

 100

 100

 100

 100

 100

 100

 100

 100

1,000

 100

 100

 300

 300

 100

100

 100

 300

 1,100

 100

 100

 100

 800

 100

 100

 100

 200

 2,800

 200

 400

 100

1,700

 1,100

 200

 3,000

 600

 100

100.00

100.00

100.00

100.00

85.00

90.00

92.50

92.50

92.50

95.00

95.00

95.00

97.50

100.00

85.00

90.00

92.50

95.00

97.50

65.00

65.00

65.00

65.00

65.00

67.50

67.50

67.50

67.50

70.00

70.00

72.50

72.50

75.00

75.00

77.50

65.00

67.50

70.00

72.50

75.00

77.50

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

2.61

 2.64

 2.65

 2.66

 7.25

 5.25

 4.30

 4.35

 4.45

 3.60

 3.65

 3.75

 3.10

 13.22

 7.25

 5.25

 13.10

 11.00

 3.10

3.90

 3.95

 4.00

 4.05

 4.10

 4.55

 4.65

 4.75

 4.80

 5.30

 5.35

 6.10

 6.30

 7.00

 7.20

 8.05

 48.30

 28.25

 10.65

 43.70

 35.60

 8.05

 

 

(ii)  Exercising

 

Productname,

e.g. call option

Numberofsecurities

Exercisepriceper unit (Note 4)

 

 

 

 

 

(d)  Other   dealings   (including   transactions   in   respect   of   new   securities)   (Note   3)

 

Nature of transaction

(Note 7)

Details

Price per unit

(if applicable) (Note 4)

 

 

 

 

Ap29

 

4.  OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

Full details of any agreement, arrangement or understanding between the person disclosing and 

any   other   person   relating   to   the   voting   rights   of   any   relevant   securities   under   any   option   referred   to  

on   this   form   or   relating   to   the   voting   rights  or future acquisition or disposal of any relevant securities 

to which any derivative referred to on this form is referenced. If none, this should be stated.

 

 

 

 

 

 

 

 

Is a Supplemental Form 38.5(b) attached?  (Note   8)    YES

 

 

Dateofdisclosure

4 May 2020

Contactname

Alwyn Basch

Telephone number

020 7742 7407

Name of offeree/offeror with which connected

Allergan plc

Nature of connection (Note 9)

Financial Advisor to Allergan plc

 

 

Ap31

 

 

SUPPLEMENTAL   FORM   38.5(b)

 

 

 

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 38.5(b) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DETAILS   OF OPEN POSITIONS

 

(This   form   should   be   attached   to   Form   38.5(b))   OPEN POSITIONS  (Note   1)

 

Productname,

e.g. call option

Written orpurchased

Numberofrelevant securitiestowhichtheoptionorderivativerelates

Exercise price (Note 2)

Type, e.g.American,Europeanetc.

Expiry date

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Written

Written

Written

Written

Written

Written

Written

Written

Written

Written

Written

Written

Written

Written

Written

Written

Written

Written

Written

Written

Written

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Written

Written

Written

Written

Written

Written

Written

Written

Written

Written

Written

Written

Written

Written

Written

Written

Written

Written

Written

Written

Written

Written

10,000

6,100

41,200

8,400

11,200

7,200

21,100

2,500

7,900

5,600

2,500

8,500

10,000

100,000

200

50,600

600

2,000

200

15,000

15,000

200

20,000

7,900

9,500

8,500

6,100

18,200

8,400

11,200

7,200

21,100

2,500

4,500

5,600

2,500

100

300

300

1,000

20,000

100

15,000

15,000

100

20,000

102,500

31,300

32,300

16,400

65,000

900

7,000

4,400

45,000

29,100

9,700

8,300

12,300

13,300

1,000

140,000

5,100

9,000

2,800

20,000

15,000

15,000

20,000

102,500

31,300

32,300

11,400

8,900

1,900

4,400

29,100

20,000

1,700

100,000

600

100

3,000

1,100

15,000

15,000

20,000

1,600

1,200

700

1,800

105.00

110.00

85.00

92.50

95.00

100.00

80.00

87.50

90.00

97.50

115.00

105.00

110.00

70.00

85.00

92.50

95.00

100.00

90.00

91.57

95.93

97.50

82.37

95.00

100.00

105.00

110.00

85.00

92.50

95.00

100.00

80.00

87.50

90.00

97.50

115.00

85.00

92.50

95.00

100.00

82.50

90.00

91.57

95.93

97.50

82.37

60.00

65.00

70.00

75.00

77.50

85.00

72.50

67.50

80.00

55.00

60.00

65.00

70.00

75.00

77.50

82.50

62.50

72.50

67.50

80.00

78.49

82.85

78.35

60.00

65.00

70.00

75.00

77.50

72.50

67.50

55.00

60.00

65.00

70.00

75.00

77.50

72.50

67.50

78.49

82.85

78.35

75.00

77.50

72.50

80.00

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

18SEP20

18SEP20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

18SEP20

18SEP20

18SEP20

18SEP20

 

 

 

 

Notes

 

1.  Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.

 

2.  For all prices and other monetary amounts, the currency must be stated.

 

For full details of disclosure requirements, see Rules 8 and

38.5 of the Rules. If in doubt, consult the Panel.

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
ISEBGGDUUSGDGGS

a d v e r t i s e m e n t